SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, lambda
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
SARS-CoV-2 (2019-nCoV)
ELISA, WB
Human
IgG1
4A8
SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Mouse
IgG2a, kappa
28D9
Mammalian Cells
K9N5Q8
Met1-Tyr351
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Mammalian Cells
UFO69279.1
Arg319-Lys537 (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H)
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Mammalian Cells
ULS17723.1
Arg316-Lys534
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Mammalian Cells
P0DTC2
Arg319-Phe541
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)